Literature DB >> 18836764

Long-term changes in parathyroid function after subtotal thyroidectomy for graves' disease.

Yukiko Yano1, Mitsuji Nagahama, Kiminori Sugino, Kunihiko Ito, Koichi Ito.   

Abstract

BACKGROUND: Transient hypocalcemia is one of the postoperative complications of thyroidectomy for Graves' disease, and perioperative parathyroid hormone (PTH) assays are used to predict postoperative hypocalcemia. We evaluated long-term changes in parathyroid function after surgery for Graves' disease.
METHODS: Serum PTH values were measured in Graves' patients with postoperative hypocalcemia, and those patients were followed postoperatively.
RESULTS: Subtotal thyroidectomy was performed in 275 patients with Graves' disease. Their serum calcium levels were measured on postoperative day (POD) 1, and patients with transient postoperative hypocalcemia were treated with calcium and vitamin D supplementation and followed up. The amount of calcium and vitamin D supplementation was adjusted to keep the patient's serum calcium level within the normal range. Measurement of their serum intact PTH value on POD 1 revealed normal value in 18 patients, a below normal level in 22, and an above normal level in the other 2. During the follow-up period, the serum iPTH values remained normal in 12 patients, recovered to the normal level in 21 patients, and rose above the normal range in 9 patients. The serum iPTH values of all patients eventually reached the normal range during the follow-up period. A marked difference in preoperative serum alkaline phosphatase concentration was observed between the high-iPTH patients and the normocalcemic patients.
CONCLUSIONS: The phenomenon of an elevated serum PTH level after surgery for Graves' disease was observed in 21% of the patients with postoperative hypocalcemia despite the achievement of normal serum calcium levels by calcium and vitamin D supplementation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836764     DOI: 10.1007/s00268-008-9754-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  THE COURSE OF PARTIAL PARATHYROID INSUFFICIENCY AFTER THYROIDECTOMY.

Authors:  J S WADE; P GOODALL; L DEANE; T M DAUNCEY; P FOURMAN
Journal:  Br J Surg       Date:  1965-07       Impact factor: 6.939

2.  Mechanism of hypocalcaemia after thyroidectomy for thyrotoxicosis.

Authors:  W Michie; T Duncan; D W Hamer-Hodges; P D Bewsher; J M Stowers; C A Pegg; G Hems; A J Hedley
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

3.  Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.

Authors:  H Pantazi; P D Papapetrou
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

4.  Postoperative tetany in Graves disease: important role of vitamin D metabolites.

Authors:  H Yamashita; T Murakami; S Noguchi; M Shiiba; S Watanabe; S Uchino; H Kawamoto; M Toda; N Murakami
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

5.  Thyrotoxicosis and hungry bone syndrome--a cause of posttreatment hypocalcemia.

Authors:  T C Dembinski; R W Yatscoff; D E Blandford
Journal:  Clin Biochem       Date:  1994-02       Impact factor: 3.281

6.  Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.

Authors:  Sally E Carty; Michelle M Roberts; Mohamed A Virji; Laura Haywood; John H Yim
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

7.  Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.

Authors:  Todd D Beyer; Carmen C Solorzano; Richard A Prinz; Ambika Babu; Naris Nilubol; Subhash Patel
Journal:  Surgery       Date:  2007-04-26       Impact factor: 3.982

8.  Intraoperative parathyroid hormone levels measured by intact and whole parathyroid hormone assays in patients with Graves' disease.

Authors:  Masaya Kai; Hiroyuki Yamashita; Tom Cantor; Taiki Moriyama; Masae Rai; Takahiro Ogawa; Shin Watanabe; Shinya Uchino; Shiro Noguchi
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

9.  Surgical management of Graves' disease -10-year prospective trial at a single institution.

Authors:  Kiminori Sugino; Koichi Ito; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Kunihiko Ito
Journal:  Endocr J       Date:  2008-02-04       Impact factor: 2.349

10.  Intraoperative parathyroid hormone assay in patients with Graves' disease for prediction of postoperative tetany.

Authors:  Taiki Moriyama; Hiroyuki Yamashita; Shiro Noguchi; Yuji Takamatsu; Takahiro Ogawa; Shin Watanabe; Shinya Uchino; Akira Ohshima; Syoji Kuroki; Masao Tanaka
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

View more
  5 in total

1.  Hypocalcemia after Total Thyroidectomy in Graves Disease.

Authors:  Malak Al Qubaisi; Philip I Haigh
Journal:  Perm J       Date:  2019-05-17

2.  Management of Grave's disease is improved by total thyroidectomy.

Authors:  Maria Annerbo; Peter Stålberg; Per Hellman
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

3.  How useful are perioperative biochemical parameters in predicting the duration of calcium and/or vitamin D supplementation after total thyroidectomy?

Authors:  Brian Hung-Hin Lang; Kai Pun Wong
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

4.  Anesthesia and thyroid surgery: The never ending challenges.

Authors:  Sukhminder Jit Singh Bajwa; Vishal Sehgal
Journal:  Indian J Endocrinol Metab       Date:  2013-03

5.  Serum intact parathyroid hormone level after total thyroidectomy or total thyroidectomy plus lymph node dissection for thyroid nodules: report from 296 surgical cases.

Authors:  Yukiko Yano; Chie Masaki; Kiminori Sugino; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Sibuya; Koichi Ito
Journal:  Int J Endocrinol Metab       Date:  2012-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.